FDX vs STRO · P/E 18, rev $87.93B vs rev $62.0M
FedEx Corporation (FDX) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported FDX revenue for 2025-05-31 was $87.93B. Net income was $4.09B. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
FDX currently screens at market cap $78.98B and trailing P/E 17.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the FDX and STRO stock pages for the full models.
Not investment advice.